ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

MTFB Motif Bio Plc

0.50
0.00 (0.00%)
31 Jan 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Motif Bio Plc LSE:MTFB London Ordinary Share GB00BVVT4H71 ORD 0.01P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.50 0.40 0.55 - 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Motif Bio Share Discussion Threads

Showing 9526 to 9543 of 9925 messages
Chat Pages: Latest  385  384  383  382  381  380  379  378  377  376  375  374  Older
DateSubjectAuthorDiscuss
26/5/2021
20:50
Isn't that correct that if you want you can sell the warrants for 30p if you want sounds good??
tnt99
26/5/2021
20:33
Considering my sister recovered from milord leukaemia after using my Tcells maybe this is karma and I wish them every success after all it's a great thing to be doing and maybe intclam can be sold in the future does anyone know if we still will benefit if that is the case??
tnt99
26/5/2021
20:30
"No value for the deferred tax payment of $18 million as far as I can see. Guess nee shareholders will gain the benefit" And, surely, anyone who continues to hold until after the taxman has done his calculations??
small crow
26/5/2021
20:27
Jonathan Gold has creamed it

The only hope here is that Iclaprim is worth a lot and I mean a lot and they have kept any news back on purpose to announce soon so that shareholders hold their shares.

No value for the deferred tax payment of $18 million as far as I can see. Guess nee shareholders will gain the benefit

Failing that this is a disastrous outcome (Bruce says he thrilled and its value - amazingly deluded) but I will vote for it as clearly after loads of interest they said they had this is the best deal they could conjure up then you might as well fail well which is what this is all about now.

scottdavid70
26/5/2021
17:27
Well Jon Gold did well despite his Robin Hood act

2021 Warrants over 2,396,269 New Ordinary Shares at the Placing Price are to be issued to Existing Directors and an existing consultant (of which 2,103,200 of these 2021 Warrants, being equal to 2 per cent. of the Enlarged Share Capital, will be granted to Jonathan Gold) in exchange for forgiveness of all accrued bonuses and other payments that would be due (a total of over an aggregate of more than US$500,000). 1,472,240 of the warrants to be granted to Jon Gold will be capable of exercise immediately upon grant with the other 630,960 of the warrants vesting at 6‐monthly intervals over 3 years.

No one else did

scottdavid70
26/5/2021
16:18
they are targeting antigens CD7 and CD33 these will only be co expressed in about 1/4 of all leukaemia patients. This is still a very large market for a disease with an awful 5 survival rate.
40 fathoms
26/5/2021
16:05
The approach that BiVictriX are taking is beautifully elegant. By going after two cancer specific antigens you will almost eliminate any toxicity in non targeted cells. Need to see the details and work out where they are in with the clinical program but this has real potential. Acute Myeloid Leukaemia would seem like the first target.
40 fathoms
26/5/2021
15:43
Interesting.
small crow
26/5/2021
15:40
Post RTO Ora Capital will hold 6.2% .... that is a Richard Griffiths vehicle. Also Robert Keith will have 6.2% he is/was a director and substantial at Silence Tx. Also the new Chairman Ian Ross has long associations with Silence Tx and was reappointed as chairman 18 months ago.
40 fathoms
26/5/2021
15:02
What's your take Scott? Which charity will you donate to?
small crow
26/5/2021
14:40
I like the look of the warrants.
small crow
26/5/2021
14:37
Consolidation on the reverse takeover 1 share per 220 new shares - wipe out for existing holders much as I expected
catch007
26/5/2021
14:33
Although it says existing shareholders also get warrants on 1 for 2 basis. Great
pejaten
26/5/2021
14:29
Great news. 1 for 220 consolidation, with placing at 20p. Wish there was an open offer as well!!
pejaten
26/5/2021
14:28
the Company has now executed a sale and purchase agreement ("SPA") to conditionally acquire the entire issued and to be issued share capital of BiVictriX Therapeutics Limited ("BiVictriX" or "BVX"), a UK-based Antibody-Drug Conjugate ("ADC") discovery and development company which is focused on leveraging clinical experience to develop a class of highly selective, next generation cancer therapeutics which exhibit superior potency, whilst reducing harmful side-effects (the "Proposed Transaction" or "Acquisition").
orchestralis
26/5/2021
11:43
You're American then Scott?
small crow
26/5/2021
08:43
Did the last RNS mean to say the AIm admission document would be out “later than May” rather than “later in May”

Wouldn’t be the first mistake these Directors would have made in the ‘best interests of shareholders’ is it?

scottdavid70
26/5/2021
08:05
RNS will come out on Friday 4.30pm as it’s a long weekend. Longer time to hide like they always have.

Bank holiday Monday 31st May

Board of Directors TO DO LIST:

Air ticket to USA - BOOKED
Taxi to airport- BOOKED
PCR test - BOOKED
Mask - check
Final check- CASHED

scottdavid70
Chat Pages: Latest  385  384  383  382  381  380  379  378  377  376  375  374  Older

Your Recent History

Delayed Upgrade Clock